ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

Blackburn Wins BMS Award

May 23, 2003

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

July 11, 2003

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

CTRC, UCLA Receive Gifts; NCCF Distributes Gold Pins.

March 24, 2000